Recent advancements in childhood cancer treatment have significantly increased five-year survival rates to over 85 percent. As a result, healthcare professionals are now focusing on the long-term health and well-being of survivors, rather than survival alone. Dr. Tara O. Henderson, in a review published in Pediatric Research, discusses the long-term consequences of cancer therapy as part of the American Pediatric Society’s 2026 Norman J. Siegel New Member Outstanding Science Award lecture. Her presentation emphasizes the “cost of cure,” particularly the greater risk of subsequent malignant neoplasms.
Despite the strides made in pediatric cancer survival, survivors face ongoing health challenges. Approximately 40 percent of childhood cancer survivors experience severe health complications within 30 years of their diagnosis. These individuals are at an eight-fold higher risk of developing serious health conditions compared to their siblings.
To address these ongoing issues, the field of survivorship science has evolved by integrating findings across various research areas. Dr. Henderson’s lecture draws from decades of epidemiological studies, the development of survivorship guidelines, and intervention strategies to showcase advancements in the field. These initiatives have improved the clinical identification of high-risk survivors and the creation of risk-based surveillance guidelines, facilitating tailored medical care.
Although long-term surveillance is crucial for identifying and managing late effects of treatment, adherence to these recommendations among patients remains low. This problem is exacerbated when survivors transition from specialized cancer centers to community medical settings, which occurs for over 85 percent of these individuals. In these community environments, many encounter disparities in care due to the limited familiarity of providers with survivorship guidelines and existing structural barriers to healthcare access.
Dr. Henderson suggests that utilizing digital technologies and establishing patient-centered data ecosystems could help address the survivorship care gap. These strategies may ensure that the journey does not end with a cure, but instead marks the beginning of a commitment to lifelong health and well-being.
The special article articulates these insights within a structured conceptual framework designed to guide survivorship and outcomes research.
Subject of Research: Lifelong health outcomes and late effects among childhood cancer survivors
Article Title: Cure is not the finish line: survivorship science improves lifelong outcomes in pediatrics.
Article References: Henderson, T. O. (2026). Cure is not the finish line: survivorship science improves lifelong outcomes in pediatrics. Pediatric Research. https://doi.org/10.1038/s41390-026-05437-y
